PanTheryx
US-based PanTheryx, Inc. manufactures medical products for diverse health conditions, serving global healthcare professionals.
Founded
2007US-based PanTheryx, Inc. manufactures medical products for diverse health conditions, serving global healthcare professionals.
Founded in Boulder, United States, PanTheryx, Inc. is a premier health and nutrition company dedicated to pioneering excellence in nutritional supplements. The company's core mission is to enhance global health through innovative medical products and nutritional solutions. PanTheryx offers a range of products, including TruBiotics, Life’s First Naturals, and DiaResQ, focusing on conditions such as Alzheimer's disease, diabetic neuropathy, and gastroesophageal reflux disease. Their market focus spans healthcare professionals in the United States and India.
PanTheryx has garnered attention for its notable leadership and investors who have significantly contributed to its growth. The company has achieved key milestones in the development and distribution of colostrum-based products, which are backed by scientific research. PanTheryx's impact is evident in its commitment to improving health outcomes through advanced nutritional supplements, making significant strides in both the medical and consumer health markets.
Companies similar to PanTheryx include Panacea Life Sciences Holdings, Panoxol, Theralogix and Targeted Medical Pharma.
PanTheryx was founded in 2007.
PanTheryx's headquarters is located in Boulder, CO, US.
PanTheryx's most recent funding round was for $52.3M (USD) in October 2023.
As of Oct 11, 2023, PanTheryx has disclosed funding of $190.3M (USD). Undisclosed round amounts are excluded.
PanTheryx has 75 employees as of Feb 5, 2024.
Targeted Medical Pharma
